Next-generation sequencing as input for chemometrics in differential sensing routines.
暂无分享,去创建一个
Sara Goodwin | Andrew D Ellington | Eric V Anslyn | Alexandra M Gade | Michelle Byrom | Baine Herrera | Camille Spears | Sara Goodwin | A. Ellington | E. Anslyn | M. Byrom | A. Gade | Baine Herrera | C. Spears
[1] Vincent M Rotello,et al. Detection and differentiation of normal, cancerous, and metastatic cells using nanoparticle-polymer sensor arrays , 2009, Proceedings of the National Academy of Sciences.
[2] John P Nolan,et al. Suspension array technology: evolution of the flat-array paradigm. , 2002, Trends in biotechnology.
[3] A. Ellington,et al. Inhibition of Cell Proliferation by an Anti-EGFR Aptamer , 2011, PloS one.
[4] Sichun Zhang,et al. Protein sensing and cell discrimination using a sensor array based on nanomaterial-assisted chemiluminescence. , 2011, Analytical chemistry.
[5] B. Sullenger,et al. Aptamers: an emerging class of therapeutics. , 2005, Annual review of medicine.
[6] Vincent M. Rotello,et al. Array-based sensing of normal, cancerous, and metastatic cells using conjugated fluorescent polymers. , 2010, Journal of the American Chemical Society.
[7] V. Rotello,et al. Differentiation of cancer cell type and phenotype using quantum dot-gold nanoparticle sensor arrays. , 2013, Cancer letters.
[8] D. Bigner,et al. Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosis , 2009, Biological chemistry.
[9] J. McNamara,et al. Cell-specific aptamers for targeted therapies. , 2009, Methods in molecular biology.
[10] R. Buhmann,et al. Aptamers—basic research, drug development, and clinical applications , 2005, Applied Microbiology and Biotechnology.
[11] Anthony D. Keefe,et al. Aptamers as therapeutics , 2010, Nature Reviews Drug Discovery.
[12] Hildegarde Heymann,et al. Discrimination of flavonoids and red wine varietals by arrays of differential peptidic sensors , 2011 .
[13] E. Anslyn. Supramolecular analytical chemistry. , 2007, The Journal of organic chemistry.
[14] N. Janjić,et al. Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor. , 1995, Chemistry & biology.
[15] Vincent M. Rotello,et al. Cell surface-based differentiation of cell types and cancer states using a gold nanoparticle-GFP based sensing array , 2010 .
[16] J. Kjems,et al. RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1. , 2010, Biochemistry.
[17] P. Seeburg,et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells , 1984, Nature.
[18] N. Janjić,et al. Oligonucleotide NX1838 inhibits VEGF165-mediated cellular responses in vitro , 1999, In Vitro Cellular & Developmental Biology - Animal.
[19] Gwendolyn M. Stovall,et al. Technical and biological issues relevant to cell typing with aptamers. , 2009, Journal of proteome research.
[20] Weihong Tan,et al. Cell-specific internalization study of an aptamer from whole cell selection. , 2008, Chemistry.
[21] Subinoy Rana,et al. Array-based sensing of metastatic cells and tissues using nanoparticle-fluorescent protein conjugates. , 2012, ACS nano.
[22] Amy C Yan,et al. A General RNA Motif for Cellular Transfection , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[23] Shannon E. Stitzel,et al. Cross-reactive chemical sensor arrays. , 2000, Chemical reviews.
[24] Yuexiang Lu,et al. Aptamer-based plasmonic sensor array for discrimination of proteins and cells with the naked eye. , 2013, Analytical chemistry.
[25] Sara Stewart,et al. The use of principal component analysis and discriminant analysis in differential sensing routines. , 2014, Chemical Society reviews.
[26] J. Segall,et al. Local signaling by the EGF receptor , 2003, The Journal of cell biology.
[27] Leo A. Joyce,et al. Uses of Differential Sensing and Arrays in Chemical Analysis , 2012 .
[28] D. S. Coffey,et al. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. , 2002, Cancer research.
[29] A. Ellington,et al. Identifying Protein Variants with Cross‐Reactive Aptamer Arrays , 2011, Chembiochem : a European journal of chemical biology.
[30] Kenneth S Suslick,et al. A colorimetric sensor array for organics in water. , 2005, Journal of the American Chemical Society.
[31] David C. Zhu,et al. Magnetic glyco-nanoparticles: a tool to detect, differentiate, and unlock the glyco-codes of cancer via magnetic resonance imaging. , 2010, Journal of the American Chemical Society.
[32] Clive Brown,et al. Toward clinical proteomics on a next-generation sequencing platform. , 2011, Analytical chemistry.
[33] P. D. Cook,et al. Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets. , 1993, Journal of medicinal chemistry.
[34] S. Jayasena. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. , 1999, Clinical chemistry.